sub field
BiotechDrug DiscoveryLongevity
stage
Startup
About
LongGame is a London-based venture capital firm founded in 2024 by crypto investor Will Harbone, with a $40M debut fund (LongGame Fund I L.P., domiciled in Jersey) focused exclusively on longevity biotechnology. The firm backs pre-seed and seed-stage companies pursuing radical life extension, with a portfolio spanning drug discovery, biotech platforms, and longevity tools. Harbone brings a crypto/Web3 background to the longevity thesis, positioning LongGame at the intersection of biotech and blockchain-enabled biomedical innovation.
Areas of interest
longevitybiotechdrug discoverylife extensioncryptoblockchainpre-seed investingseed-stage biotechbiomedical platforms